Obstructive sleep apnoea: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• GLP-1 6
• NRF2 0
• NLRP3 1
• HIF-1 0
• AKT 0
• GIP 0
• JAK 0
• MAPK 0
• PI3K 0
• SGLT2 0
• STAT3 0
• TLR4 0
• AMPK 0
• AQP4 0
• BDNF 1
• CTNNB1 0
• MAPT 0
• METTL3 0
• SIRT1 0
• TIGIT 0
• ALK 0
• CD20 0
• CFTR 0
• CGRP 0
• ERK 0
• GPX4 0
• HDAC 0
• HMGB1 0
• IL-6 0
• JNK 0
• mTOR 0
• PCSK9 0
• PINK1 0
• PKM2 0
• PPAR 0
• STING 0
• TP53 0
• YAP 0

1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NINDS · F31

  Slow-Wave Sleep Enhancement to Treat Epilepsy

  University of California at Davis· Davis, United States· US$43,749 awarded in fiscal year 2026· until Sept 2029

• NIH NIA · R56

  Breathing therapy to improve clearance of brain toxins in elder poor sleepers

  University of Miami School of Medicine· Coral Gables, United States· US$635,301 awarded in fiscal year 2026· until Aug 2027

• NIH NHLBI · R01

  Intermittent Hypoxemia in Early Life among Preterms (I-HELP) Sleep

  Northwestern University· Chicago, United States· US$2,332,060 awarded in fiscal year 2026· until Jun 2030

• NIH NHLBI · R43

  Feasibility testing of a novel in-ear sensor system for ambulatory neurological sleep monitoring to enable accessible diagnosis of sleep disorders

  Eerdx Inc· Denver, United States· US$314,318 awarded in fiscal year 2026· until Aug 2027

• NIH NICHD · R01

  The Benefits, Risks, and Long-term Impact of GLP-1 Receptor Agonists in Children

  Indiana University Indianapolis· Indianapolis, United States· US$1,589,979 awarded in fiscal year 2026· until Aug 2030

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  from DEep BREaths to deep Memories: the role of respiration in stabilizing memories during sleep (DEBREM)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Germany· EU contribution €189,687· until Sept 2027

  The disease is named only in the funder's project summary, not in the title.

6 of 299 running projects, newest first. Listed amounts together: US$190.8m + €189.7k.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

• Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea

  NCT07846865· Woolcock Institute of Medical Research· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 5
• Organoids 2
• Mendelian Randomization Analysis 16
• Gene Expression Profiling 13
• Sequence Analysis, RNA 4
• Exome Sequencing 1
• Proteomics 6
• Metabolomics 6
• Flow Cytometry 1
• Immunohistochemistry 1
• Positron-Emission Tomography 7
• Magnetic Resonance Imaging 47
• Machine Learning 50
• Deep Learning 16
• Cohort Studies 96
• Genome-Wide Association Study 15

• [Research on obstructive sleep apnea and sleep bruxism].

  Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, Nov 2026

• [A multi-cohort clinical study of magnesium metabolism dysregulation in patients with obstructive sleep apnea].

  Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, Nov 2026

• Exploring the shared genetic architecture between post-traumatic stress disorder (PTSD) and obstructive sleep apnea (OSA).

  Eur J Psychotraumatol, Aug 2026

• Sleep and aging: The role of DNA methylation.

  Exp Gerontol, Jun 2026

• Obstructive Sleep Apnea Associated with Periodontitis: Evidence from Mendelian Randomization and Salivary Proteomics.

  J Proteome Res, Apr 2026

• Genetic assessment of the causal relationship between obstructive sleep apnea and pulmonary hypertension: Mendelian randomization and meta-analysis.

  Respir Med, Mar 2026

• Exploring the causal relationship between plasma proteins and obstructive sleep apnea: a study using genome-wide Mendelian randomization, single-cell RNA sequencing analysis, and network pharmacology.

  Naunyn Schmiedebergs Arch Pharmacol, Feb 2026

• The association between obstructive sleep apnea and frailty traits: a bidirectional Mendelian randomization study.

  BMC Pulm Med, Feb 2026

• Assessing the causal association between obstructive sleep apnea and the risk of atrial fibrillation.

  Medicine (Baltimore), Jan 2026

• Causal effects of modifiable risk factors on obstructive sleep apnea: A Mendelian randomization study and validation study.

  Medicine (Baltimore), Jan 2026

See which targets of this disease your abstract mentions, and go to the people working on them.